{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:40:06Z","timestamp":1793018406350,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Signet-ring cell carcinoma of the stomach (SRCC) is a particular gastric cancer entity. Its incidence is increasing. Its diagnosis is pathological; it corresponds to adenocarcinoma with a majority of signet-ring cells component (&gt; 50%).<\/jats:p><jats:p>These histological features give it its aggressiveness characteristics. This has repercussions on the prognostic level and implications for the alternatives of therapy, especially since some authors suggest a potential chemoresistance.<\/jats:p><jats:p>This survey aimed to identify the epidemiological, pathological, therapeutic, and prognostic characteristics of SRCC as a separate disease entity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective study of 123 patients admitted for gastric adenocarcinoma to Habib Thameur Hospital in Tunis over 11 years from January 2006 to December 2016. A comparative study was performed between 2 groups: the SRCC group with 62 patients and the non-SRCC (non-signet-ring cell carcinoma of the stomach) with 61 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of SRCC in our series was 50%. SRCC affected significantly younger patients (55 vs 62 years;<jats:italic>p<\/jats:italic>= 0.004). The infiltrative character was more common in SRCC tumors (30.6 vs 14.8%;<jats:italic>p<\/jats:italic>= 0.060), whereas the budding character was more often noted in non-SRCC tumors (78.7 vs 58.1%;<jats:italic>p<\/jats:italic>= 0.039). There was no significant difference in tumor localization between both groups. Linitis plastica was noted in 14 patients with SRCC against a single patient with non-SRCC (<jats:italic>p<\/jats:italic>= 0.001). The tumor size was more important in the non-SRCC group (6.84 vs 6.39 cm;<jats:italic>p<\/jats:italic>= 0.551). Peritoneal carcinomatosis was noted in 4.3% of cases in the SRCC group versus 2.2% of cases in the NSRCC group (<jats:italic>p<\/jats:italic>= 0.570). Total gastrectomy was more often performed in the SRCC group (87 vs 56%;<jats:italic>p<\/jats:italic>= 0.001). Resection was more often curative in the non-SRCC group (84.4 vs 78.3%;<jats:italic>p<\/jats:italic>= 0.063). Postoperative chemotherapy was more commonly indicated in the SRCC group (67.4 vs 53.3%;<jats:italic>p<\/jats:italic>= 0.339). Tumor recurrence was more common in the non-SRCC group (35.7 vs 32%;<jats:italic>p<\/jats:italic>= 0.776). The most common type of recurrence was peritoneal carcinomatosis in the SRCC group (62.5%) and hepatic metastasis in the non-SRCC group (60%;<jats:italic>p<\/jats:italic>= 0.096). The overall 5-year survival in the SRCC group was lower than in the non-SRCC group, with no statistically significant difference (47.1 vs 51.5%;<jats:italic>p<\/jats:italic>= 0.715). The overall survival was more important for SRCC in early cancer (100 vs 80%;<jats:italic>p<\/jats:italic>= 0.408), whereas it was higher for non-SRCC in advanced cancer (48.1 vs 41.9%;<jats:italic>p<\/jats:italic>= 0.635).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Apart from its epidemiological and pathological features, SRCC seems to have a worse prognosis. Indeed, it is diagnosed at a more advanced stage and has a worse prognosis in advanced cancer than non-SRCC. It is therefore to be considered as a particular entity of gastric adenocarcinoma requiring a specific therapeutic protocol where the place of chemotherapy remains to be more investigated.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12957-022-02699-8","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T05:02:58Z","timestamp":1658293378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis\u2014a cohort study of 123 patients from a non-endemic country"],"prefix":"10.1186","volume":"20","author":[{"given":"Haithem","family":"Zaafouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Jouini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Khedhiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Khanchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Cherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Mesbahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Daghmouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiem","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"Akremi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriam","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazid","family":"Benzarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhafer","family":"Hadded","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Gargouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad Ben","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis Ben","family":"Maamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"issue":"2","key":"2699_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2699_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):359\u201386.","journal-title":"Int J Cancer"},{"issue":"15","key":"2699_CR3","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.ejca.2015.07.026","volume":"51","author":"LA Anderson","year":"2015","unstructured":"Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5. Eur J Cancer. 2015;51(15):2144\u201357.","journal-title":"Eur J Cancer"},{"issue":"4","key":"2699_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1(4):505\u201327.","journal-title":"JAMA Oncol"},{"issue":"7","key":"2699_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.5858\/2004-128-765-DTITIA","volume":"128","author":"DE Henson","year":"2004","unstructured":"Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128(7):765\u201370.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2699_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.annpat.2011.08.001","volume":"31","author":"J-F Fl\u00e9jou","year":"2011","unstructured":"Fl\u00e9jou J-F. WHO classification of digestive tumors: the fourth edition. Ann Pathol. 2011;31(5):27\u201331.","journal-title":"Ann Pathol"},{"issue":"6","key":"2699_CR7","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1002\/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO;2-L","volume":"39","author":"SC Ming","year":"1977","unstructured":"Ming SC. Gastric carcinoma. A pathobiological classification. Cancer. 1977;39(6):2475\u201385.","journal-title":"Cancer"},{"key":"2699_CR8","first-page":"329","volume":"32","author":"H Sugano","year":"1982","unstructured":"Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn. 1982;32:329\u201347.","journal-title":"Acta Pathol Jpn"},{"key":"2699_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31\u201349.","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"5","key":"2699_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1245\/s10434-013-3466-8","volume":"21","author":"ZM Bamboat","year":"2014","unstructured":"Bamboat ZM, Tang LH, Vinuela E, Kuk D, Gonen M, Shah MA, et al. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol. 2014;21(5):1678\u201385.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2699_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.surg.2013.05.020","volume":"154","author":"C Gronnier","year":"2013","unstructured":"Gronnier C, Messager M, Robb WB, Thiebot T, Louis D, Luc G, et al. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma? Surgery. 2013;154(5):1093\u20139.","journal-title":"Surgery."},{"issue":"4","key":"2699_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.0.CO;2-B","volume":"67","author":"E Otsuji","year":"1998","unstructured":"Otsuji E, Yamaguchi T, Sawai K, Takahashi T. Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol. 1998;67(4):216\u201320.","journal-title":"J Surg Oncol"},{"issue":"2","key":"2699_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1620\/tjem.186.121","volume":"186","author":"T Yokota","year":"1998","unstructured":"Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Kikuchi S, et al. Signet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological types. Tohoku J Exp Med. 1998;186(2):121\u201330.","journal-title":"Tohoku J Exp Med"},{"issue":"1-2","key":"2699_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000111096","volume":"72","author":"C Li","year":"2007","unstructured":"Li C, Kim S, Lai JF, Hyung WJ, Choi WH, Choi SH, et al. Advanced gastric carcinoma with signet ring cell histology. Oncology. 2007;72(1-2):64\u20138.","journal-title":"Oncology."},{"issue":"12","key":"2699_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1445-1433.2004.03268.x","volume":"74","author":"DY Kim","year":"2004","unstructured":"Kim DY, Park YK, Joo JK, Ryu SY, Kim YJ, Kim SK, et al. Clinicopathological characteristics of signet ring cell carcinoma of the stomach. ANZ J Surg. 2004;74(12):1060\u20134.","journal-title":"ANZ J Surg"},{"key":"2699_CR16","first-page":"1","volume":"11","author":"C Zhang","year":"2021","unstructured":"Zhang C, Liu R, Zhang W-H, Chen X-Z, Liu K, Yang K, et al. Difference between signet ring cell gastric cancers and non-signet ring cell gastric cancers: a systematic review and meta-analysis. Front Oncol. 2021;11:1\u201312.","journal-title":"Front Oncol"},{"issue":"28","key":"2699_CR17","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1200\/JCO.2012.42.6635","volume":"30","author":"S Taghavi","year":"2012","unstructured":"Taghavi S, Jayarajan SN, Davey A, Willis AI. Prognostic significance of signet ring gastric cancer. J Clin Oncol. 2012;30(28):3493\u20138.","journal-title":"J Clin Oncol"},{"key":"2699_CR18","unstructured":"Ksantini R, Hmila F. L\u2019ad\u00e9nocarcinome gastrique. 2012. (Monographie de l\u2019Association Tunisienne de Chirurgie)."},{"issue":"1","key":"2699_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10120-013-0234-1","volume":"17","author":"KJ Kwon","year":"2014","unstructured":"Kwon KJ, Shim KN, Song EM, Choi JY, Kim SE, Jung HK, et al. Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer. 2014;17(1):43\u201353.","journal-title":"Gastric Cancer"},{"issue":"5","key":"2699_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/den.12471","volume":"27","author":"Y Yamamoto","year":"2015","unstructured":"Yamamoto Y, Fujisaki J, Omae M, Hirasawa T, Igarashi M. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27(5):551\u201361.","journal-title":"Dig Endosc"},{"issue":"6","key":"2699_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00432-002-0336-3","volume":"128","author":"S Matsuyama","year":"2002","unstructured":"Matsuyama S, Ohkura Y, Eguchi H, Kobayashi Y, Akagi K, Uchida K, et al. Estrogen receptor beta is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol. 2002;128(6):319\u201324.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"2699_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/jso.23097","volume":"106","author":"WS Ryu","year":"2012","unstructured":"Ryu WS, Kim JH, Jang YJ, Park SS, Um JW, Park SH, et al. Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol. 2012;106(4):456\u201361.","journal-title":"J Surg Oncol"},{"issue":"5","key":"2699_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF00308791","volume":"22","author":"M Matsui","year":"1992","unstructured":"Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today. 1992;22(5):421\u20135.","journal-title":"Surg Today"},{"issue":"3","key":"2699_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354\u201362.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2699_CR25","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1245\/s10434-012-2862-9","volume":"20","author":"SR Markar","year":"2013","unstructured":"Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between west and east. Ann Surg Oncol. 2013;20(7):2328\u201338.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2699_CR26","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1245\/s10434-014-3608-7","volume":"21","author":"JH Shim","year":"2014","unstructured":"Shim JH, Song KY, Jeon HM, Park CH, Jacks LM, Gonen M, et al. Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis. Ann Surg Oncol. 2014;21(7):2332\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2699_CR27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/000313489906501004","volume":"65","author":"CP Theuer","year":"1999","unstructured":"Theuer CP, Nastanski F, Brewster WR, Butler JA, Anton-Culver H. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. Am Surg. 1999;65(10):915.","journal-title":"Am Surg"},{"issue":"12","key":"2699_CR28","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.ejso.2014.04.019","volume":"40","author":"G Piessen","year":"2014","unstructured":"Piessen G, Messager M, Lefevre J, Go\u00e9r\u00e9 D, Mabrut J-Y, Meunier B, et al. Signet ring cell adenocarcinomas: different clinical\u2013pathological characteristics of oesophageal and gastric locations. Eur J Surg Oncol. 2014;40(12):1746\u201355.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"2699_CR29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1245\/s10434-013-3462-z","volume":"21","author":"U Heger","year":"2014","unstructured":"Heger U, Blank S, Wiecha C, Langer R, Weichert W, Lordick F, et al. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Ann Surg Oncol. 2014;21(5):1739\u201348.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2699_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.lpm.2013.07.024","volume":"43","author":"T Tabouret","year":"2014","unstructured":"Tabouret T, Dhooge M, Rouquette A, Brezault C, Beuvon F, Chaussade S, et al. Ad\u00e9nocarcinome gastrique \u00e0 cellules ind\u00e9pendantes: une entit\u00e9 \u00e0 part. Presse Med. 2014;43(4):353\u20137.","journal-title":"Presse Med"},{"issue":"40","key":"2699_CR31","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.3748\/wjg.v21.i40.11428","volume":"21","author":"S Pernot","year":"2015","unstructured":"Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2699_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.surg.2010.07.006","volume":"149","author":"J Tong","year":"2011","unstructured":"Tong J, Sun Z, Wang Z, Zhao Y, Huang B, Li K, et al. Early gastric cancer with signet-ring cell histologic type: risk factors of lymph node metastasis and indications of endoscopic surgery. Surgery. 2011;149(3):356\u201363.","journal-title":"Surgery."},{"issue":"16","key":"2699_CR33","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1016\/j.ejca.2012.07.029","volume":"48","author":"MP Lutz","year":"2012","unstructured":"Lutz MP, Zalcberg JR, Ducreux M, Ajani JA, Allum W, Aust D, et al. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer\u2013differential treatment strategies for subtypes of early gastroesophageal cancer. Eur J Cancer. 2012;48(16):2941\u201353.","journal-title":"Eur J Cancer"},{"issue":"6","key":"2699_CR34","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/SLA.0b013e3181b21c7b","volume":"250","author":"G Piessen","year":"2009","unstructured":"Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg. 2009;250(6):878\u201387.","journal-title":"Ann Surg"},{"issue":"4","key":"2699_CR35","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1245\/s10434-012-2687-6","volume":"20","author":"C Mariette","year":"2013","unstructured":"Mariette C, Bruy\u00e8re E, Messager M, Pichot-Delahaye V, Paye F, Dumont F, et al. Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery? Ann Surg Oncol. 2013;20(4):1240\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2699_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.gtc.2013.01.002","volume":"42","author":"P Correa","year":"2013","unstructured":"Correa P. Gastric cancer: overview. Gastroenterol Clin N Am. 2013;42(2):211\u20137.","journal-title":"Gastroenterol Clin N Am"},{"issue":"1","key":"2699_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12957-021-02157-x","volume":"19","author":"L Jiang","year":"2021","unstructured":"Jiang L, Ma Z, Ye X, Kang W, Yu J. Clinicopathological factors afecting the efect of neoadjuvant chemotherapy in patients with gastric cancer. World J Surg Oncol. 2021;19(1):44.","journal-title":"World J Surg Oncol"},{"key":"2699_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12957-022-02544-y","volume":"20","author":"H Biao","year":"2022","unstructured":"Biao H, Zou R-P, Gan Y-W, Zhu Y-H, Ren S-M, Hou W-Z, et al. A population-based predictive model to identify patients with signet ring cell carcinoma of the stomach who are most suitable for primary tumor resection. World J Surg Oncol. 2022;20:87.","journal-title":"World J Surg Oncol"},{"issue":"10","key":"2699_CR39","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1002\/1097-0142(19901115)66:10<2162::AID-CNCR2820661020>3.0.CO;2-N","volume":"66","author":"JR Jass","year":"1990","unstructured":"Jass JR, Sobin LH, Watanabe H. The World Health Organization\u2019s histologic classification of gastrointestinal tumors: a commentary on the second edition. Cancer. 1990;66(10):2162\u20137.","journal-title":"Cancer."},{"issue":"28","key":"2699_CR40","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1200\/JCO.2011.35.8028","volume":"30","author":"PL Kunz","year":"2012","unstructured":"Kunz PL, Gubens M, Fisher GA, Ford JM, Lichtensztajn DY, Clarke CA. Long-term survivors of gastric cancer: a California population-based study. J Clin Oncol. 2012;30(28):3507\u201315.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2699_CR41","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1245\/s10434-012-2254-1","volume":"19","author":"S Lorenzen","year":"2012","unstructured":"Lorenzen S, Blank S, Lordick F, Siewert J-R, Ott K. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients. Ann Surg Oncol. 2012;19(7):2119\u201327.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2699_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11605-009-1127-9","volume":"14","author":"M Zhang","year":"2010","unstructured":"Zhang M, Zhu G, Zhang H, Gao H, Xue Y. Clinicopathologic features of gastric carcinoma with signet ring cell histology. J Gastrointest Surg. 2010;14(4):601\u20136.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"2699_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1365-2168.2000.01358.x","volume":"87","author":"Y Maehara","year":"2000","unstructured":"Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000;87(3):353\u20137.","journal-title":"Br J Surg"},{"issue":"12","key":"2699_CR44","first-page":"682","volume":"34","author":"HG Hass","year":"2011","unstructured":"Hass HG, Smith U, J\u00e4ger C, Schaeffer M, Wellhaeusser U, Hehr T, et al. Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren\u2019s): single-center experience of 160 cases. Oncol Res Treat. 2011;34(12):682\u20136.","journal-title":"Oncol Res Treat"},{"issue":"10","key":"2699_CR45","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/bjs.4637","volume":"91","author":"C Kunisaki","year":"2004","unstructured":"Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Akiyama H. Therapeutic strategy for signet ring cell carcinoma of the stomach. Br J Surg. 2004;91(10):1319\u201324.","journal-title":"Br J Surg"},{"issue":"4","key":"2699_CR46","first-page":"841","volume":"7","author":"H Takiuchi","year":"2000","unstructured":"Takiuchi H, Hirata I, Kawabe S, Egashira Y, Katsu K. Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma. Oncol Rep. 2000;7(4):841\u20137.","journal-title":"Oncol Rep"},{"issue":"5","key":"2699_CR47","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/SLA.0b013e3182352647","volume":"254","author":"M Messager","year":"2011","unstructured":"Messager M, Lefevre JH, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C, et al. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011;254(5):684\u201393.","journal-title":"Ann Surg"},{"issue":"9","key":"2699_CR48","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/0959-8049(94)90171-6","volume":"30","author":"P Rougier","year":"1994","unstructured":"Rougier P, Mahjoubi M, Lasser P, Ducreux M, Oliveira J, Ychou M, et al. Neoadjuvant chemotherapy in locally advanced gastric carcinoma\u2014a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. Eur J Cancer. 1994;30(9):1269\u201375.","journal-title":"Eur J Cancer"},{"key":"2699_CR49","unstructured":"Voron T. Les ad\u00e9nocarcinomes \u00e0 cellules ind\u00e9pendantes: une entit\u00e9 particuli\u00e8re au sein des cancers gastriques? 2014 \u27e8dumas-01132575\u27e9"},{"issue":"16","key":"2699_CR50","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1200\/JCO.2012.47.4338","volume":"31","author":"G Piessen","year":"2013","unstructured":"Piessen G, Messager M, Robb WB, Bonnetain F, Mariette C. Gastric signet ring cell carcinoma: how to investigate its impact on survival. J Clin Oncol. 2013;31(16):2059\u201360.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2699_CR51","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1007\/s00464-012-2371-8","volume":"26","author":"PWY Chiu","year":"2012","unstructured":"Chiu PWY, Teoh AYB, To KF, Wong SKH, Liu SYW, Lam CC, et al. Endoscopic submucosal dissection (ESD) compared with gastrectomy for treatment of early gastric neoplasia: a retrospective cohort study. Surg Endosc. 2012;26(12):3584\u201391.","journal-title":"Surg Endosc"},{"issue":"2","key":"2699_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jso.23261","volume":"107","author":"CW Huh","year":"2013","unstructured":"Huh CW, Jung DH, Kim J, Lee YC, Kim H, Kim H, et al. Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer. J Surg Oncol. 2013;107(2):124\u20139.","journal-title":"J Surg Oncol"},{"issue":"2","key":"2699_CR53","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1245\/s10434-007-9660-9","volume":"15","author":"TK Ha","year":"2008","unstructured":"Ha TK, An JY, Youn HK, Noh JH, Sohn TS, Kim S. Indication for endoscopic mucosal resection in early signet ring cell gastric cancer. Ann Surg Oncol. 2008;15(2):508\u201313.","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02699-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02699-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02699-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T02:00:47Z","timestamp":1676167247000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02699-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2699"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02699-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Habib Thameur Hospital of Tunisia. The need for informed consent was waived by the ethics committee in its decision. All methods were carried out following relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A statement is confirming that \u201c<i>informed consent<\/i> was obtained from all subjects and\/or their legal guardian(s).\u201d","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}